Synthesis and Optimization of Human Serum Albumin Nanoparticles for Drug Delivery Application
Subject Areas : Information Technology in Engineering Design (ITED) Journal
rabi mehravar
1
(Azad University Of Amol)
Mohsen Jahanshahi
2
(Azad university of Mashhad)
Keywords:
Abstract :
Abstract In recent years, the application of protein nanoparticles has become of more and more interest to the pharmaceutical industry. In this study,Human Serum Albumin (HSA) was used for the synthesis of nanoparticles by desolvation method for application in drug delivery system because of biodegradablity, owing to the high capacity of drug loading and nontoxiticty. Moreover, the effects of different parameters i.e. pH, HSA concentration, agitation speed, glutaraldehyde concentration, organic solvent adding rate, the ratio of organic solvent/HSA solution were examined in this research and Taguchi method with L16 orthogonal array was implemented to optimize experimental conditions. The best parameters for nanobioparticles production were obtained at pH=9, HSA concentration: 75 mg.ml-1 , ethanol adding rate: 1.5 ml.min-1 and the ratio of organic solvent/HSA solution: 4. Under these conditions, the software predicted the 46.625 nm for HSA nanoparticle size, which, in experiment 53 nm, was achieved for the nanoparticles. With respect to our study, the synthesis of human serum albumin nanoparticles was carried out for the first time and to the best of our knowledge, no reference has been found in the literature about using Taguchi method for optimization of HSA nanoparticles up to now.
1. Roy I, Ohulchanskyy T. Y, Pudavar H. E, “Ceramic-Based Nanoparticles Entrapping WaterInsoluble Photosensitizing Anticancer Drugs: A Novel Drug-Carrier System for Photodynamic Therapy”. J. Am. Chem. Soc., 125, 2003, 7860-7865 2. Bigger I, Dubernet C, Couvreur P, “Nanoparticles in Cancer Therapy and Diagnosis”. Adv Drug Deliv. Rev., 54, 2002, 631-651. 3. Crommelin D. J, Storm G, Jiskoot W, Stenekes R, Mastrobattista E and Hennink W. E, “Nanotechnological Approaches for the Delivery of Macromolecules.” J. Controlled Release, 87, 2003, 81-88 4 .اسماعیل جباری، شهریار شـریفی، ”نانوذرات و کاربرد آنها در رهایش کنترل شـده عوامـل بیولـوژیکی .“ زمستان 1382. 5. Rahimnejad M, Jahanshahi M, Njafpour G. D, “Production of biological nanoparticles from bovine serum albumin for drug delivery”. Afr. J. Biotechnol., 5(20), 2006, 1918-1923 6. Jahanshahi M, Sanati M.H, Hajizadeh S, Babaei Z, “Gelatin nanoparticle fabrication and optimization of the particle size”. Phys. Stat. sol. (a), 2008, 1-5 7. Lowe C.R, “Nanobiotechnology”, Current Opinions in Structural Biology, (2000). 8. Zhang Z, Burton S,Williams S, Lyddiat A, “Design and assembly of solid phase for the effective recovery of nanopartoculate.Bioproducts in fludised bed contactors”, Bioseparation,10, 2001, 113- 132 9. http:// nanobiotechnology.blogfa.com. 10. Jahanshahi M, Raoof JB, Hajizadeh S, Jabari Seresht R, “Synthesis and subsequent purification of carbon nanotubes by arc discharge in NaCl solution”. phys. stat. sol. (a), 2008, 1– 5 11 .جهانشــاهی، محســن،”گــزارش ســاخت از پــائین بــه بــالای یــک نانوســاخت ار پروتئینــی بــه روش . 1385 تابستان “ ، Coacervation 12. Marty JJ, Oppenheimer RC, Speiser P, "Nanoparticles-a new colloidal drug delivery system”. Pharm. Acta Helv 53, 1978, 17-23 13. Jahanshahi M, “Molecular Nanotechnology & Nanobiotechnology”, Book: Academic University (Mazandaran) publications (2007).
_||_